K

Klinique Medical Clinic PCL
SET:KLINIQ

Watchlist Manager
Klinique Medical Clinic PCL
SET:KLINIQ
Watchlist
Price: 25.25 THB -1.94%
Market Cap: ฿5.6B

Klinique Medical Clinic PCL
Other

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Klinique Medical Clinic PCL
Other Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other CAGR 3Y CAGR 5Y CAGR 10Y
K
Klinique Medical Clinic PCL
SET:KLINIQ
Other
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
D
Dental Corporation PCL
SET:D
Other
-฿12.5m
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
-127%
L
LDC Dental PCL
SET:LDC
Other
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
K
KT Medical Service PCL
SET:KTMS
Other
-฿5.9m
CAGR 3-Years
-68%
CAGR 5-Years
5%
CAGR 10-Years
N/A
G
Genesis Fertility Center PCL
SET:GFC
Other
-฿3m
CAGR 3-Years
57%
CAGR 5-Years
42%
CAGR 10-Years
N/A
No Stocks Found

Klinique Medical Clinic PCL
Glance View

Market Cap
5.6B THB
Industry
Health Care

The Klinique Medical Clinic Public Co., Ltd. engages in the provision of dermatology, aesthetics, cosmetic surgery,and wellness services. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2022-11-07. The firm is engaged in covering all skin and body problems, such as Ulthera SPT+, ThermageFLX Pro, Pico Clear Enlighten, CopperBromide, eLos Plus, eMatrix, New YAG Laser or liposuction, such as New Coolsculpting, VelaShape III, Emsculpt NEO, VASER, and BodyTite, as well as anti-aging medicine and women wellness. The firm's services include facelift, acne, acne scars, acne scars, shape up, Filler, Fat dissolving injections, laser hair removal, skin injection, Mesoface, meso, nose surgery, eye surgery, and facial surgery.

KLINIQ Intrinsic Value
42.07 THB
Undervaluation 40%
Intrinsic Value
Price
K

See Also

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett